Weight Gain and Cardiovascular Risk After Organ Transplantation
- 1 May 2001
- journal article
- review article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 25 (3), 114-119
- https://doi.org/10.1177/0148607101025003114
Abstract
Organ transplantation has become a common and effective approach to the management of patients with organ failure. The improvement in long-term survival has resulted in the emergence of cardiovascular disease as the primary cause of death in renal transplant patients and a significant complication in other organ recipients. A number of factors explain this trend, including a high incidence of hypertension, posttransplant diabetes, hyperlipidemia, and obesity risk factors that are mediated by direct effects of immunosuppressive medications. Weight gain posttransplant affects ~50% of patients and represents a significant problem because of the potential synergism between obesity and immunosuppressive medication-induced effects on cardiovascular disease risk factor development. This review discusses the incidence and implications of cardiovascular disease risk factors in organ transplant recipients, strategies for clinical management, and future research directions. (Journal of Parenteral and Enteral Nutrition 25:114-119, 2001)Keywords
This publication has 70 references indexed in Scilit:
- Role of circulating lipid abnormalities in chronic renal allograft rejectionKidney International, 1999
- Risk for posttransplant diabetes mellitus with current immunosuppressive medicationsAmerican Journal of Kidney Diseases, 1999
- Detrimental effect of dietary sodium and beneficial effect of dietary magnesium on glomerular changes in cyclosporin-A-treated spontaneously hypertensive ratsNephrology Dialysis Transplantation, 1998
- Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506Transplant International, 1998
- Editorial The Transfer of the Journal: Message from the New Editor‐in‐ChiefObesity Research, 1998
- Effects of Dietary Sodium and Magnesium on Cyclosporin A–Induced Hypertension and Nephrotoxicity in Spontaneously Hypertensive RatsHypertension, 1997
- Liver transplantation in the morbidly obeseJournal of Clinical Anesthesia, 1996
- EXCESSIVE WEIGHT GAIN AFTER LIVER TRANSPLANTATIONTransplantation, 1991
- Serial evaluation of lipid profiles and risk factors for development of hyperlipidemia after cardiac transplantationThe American Journal of Cardiology, 1990
- TOXIC EFFECTS OF CYCLOSPORINE ON THE ENDOCRINE PANCREAS OF WISTAR RATSTransplantation, 1985